These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
169 related items for PubMed ID: 8473053
1. Involvement of p53 gene mutations in human endometrial carcinomas. Honda T, Kato H, Imamura T, Gima T, Nishida J, Sasaki M, Hoshi K, Sato A, Wake N. Int J Cancer; 1993 Apr 01; 53(6):963-7. PubMed ID: 8473053 [Abstract] [Full Text] [Related]
2. Detection of p53 gene mutations in human ovarian and endometrial cancers by polymerase chain reaction-single strand conformation polymorphism analysis. Naito M, Satake M, Sakai E, Hirano Y, Tsuchida N, Kanzaki H, Ito Y, Mori T. Jpn J Cancer Res; 1992 Oct 01; 83(10):1030-6. PubMed ID: 1333465 [Abstract] [Full Text] [Related]
3. p53 gene mutations and loss of a chromosome 17p in Philadelphia chromosome (Ph1)-positive acute leukemia. Nakai H, Misawa S, Tanaka S, Nishigaki H, Taniwaki M, Yokota S, Horiike S, Takashima T, Seriu T, Nakagawa H. Leukemia; 1993 Oct 01; 7(10):1547-51. PubMed ID: 8412316 [Abstract] [Full Text] [Related]
4. p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma. von Deimling A, Eibl RH, Ohgaki H, Louis DN, von Ammon K, Petersen I, Kleihues P, Chung RY, Wiestler OD, Seizinger BR. Cancer Res; 1992 May 15; 52(10):2987-90. PubMed ID: 1349850 [Abstract] [Full Text] [Related]
5. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium. Enomoto T, Fujita M, Inoue M, Rice JM, Nakajima R, Tanizawa O, Nomura T. Cancer Res; 1993 Apr 15; 53(8):1883-8. PubMed ID: 8385572 [Abstract] [Full Text] [Related]
6. Allelic loss on chromosome 17p and p53 mutations in human endometrial carcinoma of the uterus. Okamoto A, Sameshima Y, Yamada Y, Teshima S, Terashima Y, Terada M, Yokota J. Cancer Res; 1991 Oct 15; 51(20):5632-5. PubMed ID: 1913680 [Abstract] [Full Text] [Related]
7. Poor correlation with loss of heterozygosity on chromosome 17p and p53 mutations in ovarian cancers. Sakamoto T, Nomura N, Mori H, Wake N. Gynecol Oncol; 1996 Nov 15; 63(2):173-9. PubMed ID: 8910623 [Abstract] [Full Text] [Related]
8. Chromosome 17p deletions and p53 mutations in renal cell carcinoma. Reiter RE, Anglard P, Liu S, Gnarra JR, Linehan WM. Cancer Res; 1993 Jul 01; 53(13):3092-7. PubMed ID: 8319216 [Abstract] [Full Text] [Related]
9. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations. Cornelis RS, van Vliet M, Vos CB, Cleton-Jansen AM, van de Vijver MJ, Peterse JL, Khan PM, Børresen AL, Cornelisse CJ, Devilee P. Cancer Res; 1994 Aug 01; 54(15):4200-6. PubMed ID: 8033152 [Abstract] [Full Text] [Related]
10. Mutation and allelic loss of the p53 gene in endometrial carcinoma. Incidence and outcome in 92 surgical patients. Kihana T, Hamada K, Inoue Y, Yano N, Iketani H, Murao S, Ukita M, Matsuura S. Cancer; 1995 Jul 01; 76(1):72-8. PubMed ID: 8630879 [Abstract] [Full Text] [Related]
12. p53 gene mutations in medulloblastoma. Immunohistochemistry, gel shift analysis, and sequencing. Badiali M, Iolascon A, Loda M, Scheithauer BW, Basso G, Trentini GP, Giangaspero F. Diagn Mol Pathol; 1993 Mar 01; 2(1):23-8. PubMed ID: 8287222 [Abstract] [Full Text] [Related]
13. High frequency of chromosome 9p allelic loss and CDKN2 tumor suppressor gene alterations in squamous cell carcinoma of the bladder. Gonzalez-Zulueta M, Shibata A, Ohneseit PF, Spruck CH, Busch C, Shamaa M, El-Baz M, Nichols PW, Gonzalgo ML, Elbaz M [corrected to El-Baz M]. J Natl Cancer Inst; 1995 Sep 20; 87(18):1383-93. PubMed ID: 7658499 [Abstract] [Full Text] [Related]
14. Detection of p53 gene mutations in human brain tumors by single-strand conformation polymorphism analysis of polymerase chain reaction products. Mashiyama S, Murakami Y, Yoshimoto T, Sekiya T, Hayashi K. Oncogene; 1991 Aug 20; 6(8):1313-8. PubMed ID: 1886708 [Abstract] [Full Text] [Related]
15. Frequent p53 gene mutations in blast crisis of chronic myelogenous leukemia, especially in myeloid crisis harboring loss of a chromosome 17p. Nakai H, Misawa S, Toguchida J, Yandell DW, Ishizaki K. Cancer Res; 1992 Dec 01; 52(23):6588-93. PubMed ID: 1423304 [Abstract] [Full Text] [Related]
16. Infrequent mutations in the P53 gene in primary human T-cell acute lymphoblastic leukemia. Jonveaux P, Berger R. Leukemia; 1991 Oct 01; 5(10):839-40. PubMed ID: 1961018 [Abstract] [Full Text] [Related]
17. Polymerase chain reaction-based approaches for detection of allelic loss in the p53 tumor suppressor gene in colon neoplasms. Yamaguchi K, Sugano K, Fukayama N, Nakashima Y, Saotome K, Yokoyama T, Yokota T, Ohkura H. Am J Gastroenterol; 1997 Feb 01; 92(2):307-12. PubMed ID: 9040212 [Abstract] [Full Text] [Related]
18. [Genetic alterations and transformations in development and establishment of uterine endometrial carcinomas]. Inoue M. Nihon Sanka Fujinka Gakkai Zasshi; 1993 Aug 01; 45(8):751-62. PubMed ID: 8371006 [Abstract] [Full Text] [Related]
19. Involvement of p53 gene in the allelic deletion of chromosome 17p in human ovarian tumors. Tsao SW, Mok CH, Oike K, Muto M, Goodman HM, Sheets EE, Berkowitz RS, Knapp RC, Lau CC. Anticancer Res; 1991 Aug 01; 11(6):1975-82. PubMed ID: 1776830 [Abstract] [Full Text] [Related]
20. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection. Fujita M, Inoue M, Tanizawa O, Iwamoto S, Enomoto T. Cancer Res; 1992 Oct 01; 52(19):5323-8. PubMed ID: 1327506 [Abstract] [Full Text] [Related] Page: [Next] [New Search]